Rilpivirine D6
Product Description
CLEARSYNTH LABS LIMITED
-
Country/Region:India
-
On CPHI since:2015
-
Certificates:2
-
Employees:250 - 499
Company types
Primary activities
Categories
Specifications
CLEARSYNTH LABS LIMITED
-
Country/Region:India
-
On CPHI since:2015
-
Certificates:2
-
Employees:250 - 499
Company types
Primary activities
More Products from CLEARSYNTH LABS LIMITED (99)
-
Product Clopidogrel D3 Hydrogen sulphate
Labeled Clopidogrel, intended for use as an internal standard for the quantification of Clopidogrel by GC- or LC-mass spectrometry. -
Product Diazepam Impurity F (BP)
Impurity in commercial preparations of Diazepam -
Product Doxofylline
Doxofylline is a xanthine molecule that appears to be both bronchodilator and anti-inflammatory with an improved therapeutic window over conventional xanthines such as Theophylline and the evidence supporting the effects of Doxofylline in the treatment -
Product Rasagiline
Rasagiline, is a selective and irreversible propargylamine inhibitor of monoamine oxidase which has been used to increase the availability of dopamine at striatal receptors as a method to treat Parkinson’s disease. -
Product Papaverine
Molecular formula: C20H22ClNO4Molecular weight: 339.38 -
Product Piracetam EP Impurity C
Impurity in commercial preparation of Piracetam. -
Product Sildenafil D3
Labeled Sildenafil, intended for use as an internal standard for the quantification of Sildenafil by GC- or LC-mass spectrometry. -
Product Sumatriptan
Molecular formula: C14H21N3O2SMolecular weight: 295.14 -
Product Dexlansoprazole
Molecular formula: C16H14F3N3O2SMolecular weight: 369.36 -
Product Diatrizoic acid
Molecular formula: C11H9I3N2O4Molecular weight: 613.91 -
Product Dipyridamole D20
Selective inhibitor of phosphodiesterase V (PDE 5); potent coronary vasodilator drug; adenosine transport inhibitor; inhibitor of platelet aggregation.;Labeled Dipyridamole, intended for use as an internal standard for the quantification of Dipyridamole by GC- or LC-mass spectrometry. -
Product Raloxifene D4
Deuterated Raloxifene, a nonsteroidal estrogen receptor mixed agonist/antagonist.;Labeled Raloxifene, intended for use as an internal standard for the quantification of Raloxifene by GC- or LC-mass spectrometry.
CLEARSYNTH LABS LIMITED resources (1)
-
Video Clearsynth Intro Video
Clearsynth Labs Limited is a technology-based, research-driven, innovation-led enterprise specializing in deuterium chemistry and stable isotopes. Headquartered in Mumbai, with an R&D center in Hyderabad and a CDMO facility in Karnataka, alongside operations in Canada and the USA, we deliver solutions from milligram-scale R&D to multi-ton manufacturing. Our expertise spans deuterated APIs, intermediates, impurities, and reference standards. Backed by strong IP and 350+ scientists, we partner with innovators and generics across CDMO and CMO segments, committed to precision, quality, and advancing next-generation isotopic solutions for global pharmaceutical needs.











